|
|
|
Prof Keech awarded Vice Chancellor's Award for Excellence
GENERAL NEWS: Prof Keech awarded Vice Chancellor's Award for Excellence
30 July 2018
CTC Deputy Director, Prof Tony Keech, has been awarded the
prestigious 2018 University of Sydney Vice Chancellor's Award for
Research. One of three given for Research, the award was
established to celebrate exceptional performance at the
University. As a whole-of-University, peer-nominated reward
program, the awards recognise impact, leadership, entrepreneurship,
mentorship, and industry and community engagement as well as
outstanding performance in the support of research and education,
and professional service.
Prof Keech has co-led a team of researchers at the CTC over
the past 24 years, assisting in its growth from 24 to over 200
staff members with over 65,000 patients have been recruited to
100 multicentre trials involving more than 800 clinical
sites.
Through his leadership of landmark clinical trials and
systematic reviews, Prof Keech has played a pivotal role in
translating his research into policy and practice changes,
guidelines, new drug indications and PBS subsidy support criteria.
His research continues to influence the treatment of people with a
myocardial infarct or those at risk of cardiovascular disease
(CVD), the health outcomes of premature babies, and clinician
training in both clinical medicine and medical research.
Prof Keech is internationally known in
the field of cardiovascular clinical trials, and is well recognised
for his collaborative research into coronary risk factors,
treatments for acute coronary syndromes, prediction of vascular
disease and treatment and diabetes complication prevention
He has been awarded/co-awarded a
career total of over $256M in government and industry grants,
including over $ 39M in the last five years; has held an NHMRC
Research Fellowship since 1997; and has received NHMRC block or
programme grant funding for 20 years (over $37m). He has
authored/co-authored over 260 peer-reviewed publications, including
220 journal articles, with 46 of his papers cited over 100 times,
and 15 of these cited between 500 and 6,500 times. Over the past
five years alone, he has supervised 11 postgraduate students, and
dozens of medical and science students. He also directs a
successful Masters in Clinical Trials Research programme,
graduating over 45 graduate clinician researchers to date.
|
|
|